LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.12 | uM | LJP5 | 2 | M23 | 72 | hr | 1401 | 3861 | 4223 | 0.9143 | 0.8717 |
| SK-BR-3 | Erlotinib | 0.12 | uM | LJP5 | 3 | M23 | 72 | hr | 1401 | 4138 | 4223 | 0.9799 | 0.9698 |
| SK-BR-3 | Foretinib | 0.12 | uM | LJP5 | 1 | H11 | 72 | hr | 1401 | 4026 | 4223 | 0.9533 | 0.9302 |
| SK-BR-3 | Foretinib | 0.12 | uM | LJP5 | 2 | H11 | 72 | hr | 1401 | 4395 | 4223 | 1.0407 | 1.0609 |
| SK-BR-3 | Foretinib | 0.12 | uM | LJP5 | 3 | H11 | 72 | hr | 1401 | 4806 | 4223 | 1.1380 | 1.2066 |
| SK-BR-3 | R406 | 0.12 | uM | LJP6 | 1 | C17 | 72 | hr | 1401 | 4179 | 4223 | 0.9896 | 0.9844 |
| SK-BR-3 | R406 | 0.12 | uM | LJP6 | 2 | C17 | 72 | hr | 1401 | 3962 | 4223 | 0.9382 | 0.9075 |
| SK-BR-3 | R406 | 0.12 | uM | LJP6 | 3 | C17 | 72 | hr | 1401 | 4041 | 4223 | 0.9569 | 0.9355 |
| SK-BR-3 | Pictilisib | 0.12 | uM | LJP6 | 1 | D23 | 72 | hr | 1401 | 2324 | 4223 | 0.5503 | 0.3269 |
| SK-BR-3 | Pictilisib | 0.12 | uM | LJP6 | 2 | D23 | 72 | hr | 1401 | 2114 | 4223 | 0.5006 | 0.2525 |
| SK-BR-3 | Pictilisib | 0.12 | uM | LJP6 | 3 | D23 | 72 | hr | 1401 | 2349 | 4223 | 0.5562 | 0.3358 |
| SK-BR-3 | Gefitinib | 0.12 | uM | LJP6 | 1 | N11 | 72 | hr | 1401 | 3359 | 4223 | 0.7954 | 0.6938 |
| SK-BR-3 | Gefitinib | 0.12 | uM | LJP6 | 2 | N11 | 72 | hr | 1401 | 3748 | 4223 | 0.8875 | 0.8316 |
| SK-BR-3 | Gefitinib | 0.12 | uM | LJP6 | 3 | N11 | 72 | hr | 1401 | 3601 | 4223 | 0.8527 | 0.7795 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP5 | 1 | O05 | 72 | hr | 1401 | 1251 | 4223 | 0.2962 | -0.0533 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP5 | 2 | O05 | 72 | hr | 1401 | 1624 | 4223 | 0.3846 | 0.0788 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP5 | 3 | O05 | 72 | hr | 1401 | 1806 | 4223 | 0.4277 | 0.1434 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP6 | 1 | O05 | 72 | hr | 1401 | 1521 | 4223 | 0.3602 | 0.0423 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP6 | 2 | O05 | 72 | hr | 1401 | 1527 | 4223 | 0.3616 | 0.0445 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP6 | 3 | O05 | 72 | hr | 1401 | 1412 | 4223 | 0.3344 | 0.0037 |
| SK-BR-3 | GSK1059615 | 0.12 | uM | LJP5 | 1 | E05 | 72 | hr | 1401 | 3021 | 4223 | 0.7154 | 0.5740 |
| SK-BR-3 | GSK1059615 | 0.12 | uM | LJP5 | 2 | E05 | 72 | hr | 1401 | 4357 | 4223 | 1.0317 | 1.0475 |
| SK-BR-3 | GSK1059615 | 0.12 | uM | LJP5 | 3 | E05 | 72 | hr | 1401 | 3853 | 4223 | 0.9124 | 0.8688 |
| SK-BR-3 | GSK1059615 | 0.12 | uM | LJP6 | 1 | C05 | 72 | hr | 1401 | 3336 | 4223 | 0.7899 | 0.6856 |
| SK-BR-3 | GSK1059615 | 0.12 | uM | LJP6 | 2 | C05 | 72 | hr | 1401 | 3601 | 4223 | 0.8527 | 0.7795 |